https://www.bnnbloomberg.ca/hcsc-elevance-compete-for-cigna-medicare-advantage-unit-1.2012204Health Care Service Corp. and Elevance Health Inc. are competing to acquire Cigna Group's business providing medical coverage
Novartis reveals Phase 3 data confirming remibrutinib's long-term efficacy and safety for chronic spontaneous urticaria, showing significant symptom improvement and a favorable safety profile up to Week 52.